Recent Articles
Most Popular
China Stocks
Consumer Stocks
Energy Stocks
ETFs & Mutual Funds
Global Investing
Gold & Materials Stocks
Income Investing
Industrial Stocks
Healthcare & Biotech
Technology Stocks
| Medivation (MDVN) targets Alzheimer's |
|
"Medivation continues to make good clinical trial progress with its Dimebon drug for Alzheimer’s Disease. "The firm received some mainstream media attention at the recent International Conference on Alzheimer’s Disease (ICAD) in Vienna. Reuters, Forbesand Bloomberg all reported that Dimebon is changing the way scientists think about Alzheimer’s. "Data showed that in mice and cell cultures, Dimebon increased the presence of amyloid plaque – a protein that signals Alzheimer’s. Scientists aren’t sure whether the amyloid is a cause or symptom of Alzheimer’s, but they believe there is an important relationship between amyloid and the disease. "Sam E. Gandy, a professor at Mt. Sinai Medical Center, who led the amyloid Dimebon study, said the data presented so far is 'the best thing anyone’s ever seen in Alzheimer’s.” "Not only could Dimebon be a successful drug, it could also create a better understanding of Alzheimer’s and speed development of other drugs or preventative measures. "And make no mistake… if Dimebon is proven safe and effective in Phase III trials, it will be one of the most important medical breakthroughs in recent memory – and would send Medivation’s shares soaring." |
Newsletter News & Deals
Get our Free Daily Digest
| Dividend Still Don't Lie |
Dividends Don't Lie -- by IQ Trends founder Geraldine Weiss -- is one of the all-time great investment books. Now, editor Kelley Wright is following up this classic with Dividend Still Don't Lie, which can be pre-ordered at a significant discount. |
| Rhino Stocks: Free webinar |
| Jonas Elmerraji, editor of the Rhino Stock Report has released a 29-minute webinar, Planning Your Entries and Exits With Technical Analysis. It is available free with site registration. Click here. |
| Free report from Ken Kam |
Ken Kam of Marketocracy has just published a free report outlining his 2010 strategy. To view "The New Rules for Investing", click here. |
| Meet Gordon Pape in Toronto |
Gordon Pape, editor of The Internet Walth Builder, will be speaking at the Fairmont Royal York Hotel Toronto on February 13 and 14. Click here for details. |
| Keith Fitz-Gerald: Fiscal Hangover |
Get a $10 discount on Keith's new book on global investing -- Fiscal Hangover. Click here. |
| Delfeld: Red, White & Bold |
Global expert Carl Delfeld's new book -- Red, White & Bold -- is now available. |
| Meet the KCI editors |
Join Roger Conrad, Gregg Early, Elliott Gue, Yiannis Mostrous, and Benjamin Shepherd at the Hotel del Coronado for the 2010 KCI Wealth Society Member Summit. Call 1-800-832-2330 (between 9:00 a.m. and 5:00 p.m. EST Monday through Friday) or go to www.InvestingSummit.com. |
| Toby Smith goes "green" |
Toby Smith, editor of ChangeWave Investing, has just published his new book on investing in green technology -- Billion Dollar Green. |
| An expert's guide to China |
Check out Becoming Your Own China Stock Guru, a new book by China expert Jim Trippon -- editor of The China Stock Digest. To order the book, click here. |
| EconoPower: New from Skousen |
Mark Skousen's latest book, “EconoPower: How a New Generation of Economists is Transforming the World” (Wiley & Sons), is available for $16.47 (plus shipping) from Amazon.com (retail $24.95). |
| Guide to seasonal trading |
Sy Harding, editor of Street Smart Report, has just published Beat the Market the Easy Way -- an in-depth review of seasonal market patterns and their application to long-term timing. |
| Dick Davis Dividend |
In The Dick Davis Dividend, the investing legend shares a lifetime of insights on investing. |